Revenue estimates for Nederman Holding AB (OSTO:NMAN) have increased from $5.78 billion to $5.80 billion for the full year 2024 and increased from $6.11 billion to $6.14 billion for 2025 over the past ...

Orders Received: SEK1.425 billion, currency neutral growth of 8.4%, with 3.7% organic growth. Sales: SEK1.439 billion, currency neutral growth of 5.3%, with 0.7% organic growth. Adjusted EBITDA: ...

The FX2 extraction arm captures airborne particles generated during dental procedures that can spread respiratory infection. The technology can reduce aerosol exposure for dentists, patients, and ...

Nederman Holding AB reported its second-quarter earnings for 2025, showing a mixed performance with a decline in earnings per share (EPS) to 1.97 SEK from 2.77 SEK last year. Despite this, the company ...

Nederman Holding AB (NMAN) reported its Q1 2025 earnings, revealing steady sales amid challenging market conditions. The company’s stock fell by 7.31% on the day of the announcement, reflecting ...

Nederman Holding AB reported its second-quarter 2025 earnings, revealing a mixed performance marked by innovation in product offerings but facing market uncertainties. Despite a decline in earnings ...

Good morning, everyone, and welcome to Nederman Interim Report Q3 2025. If we start with some short summaries, we can say that we had good profitability, and we continue to invest in our business. We ...

Orders received amounted to SEK 1,467m (1,396), equivalent to currency neutral growth of 4.8 percent compared with the same period last year. Net sales amounted to SEK 1,501m (1,515), equivalent to a ...